Back to announcement
20240520_INAF_Pengumuman RUPS_31640990_lamp1.pdf
RUPS notice Text extracted INAFSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.937
4G,
indofarma
Member of Biofarma Group
ANNOUNCEMENT
ANNUAL GENERAL MEETING OF SHAREHOLDERS
FOR THE FINANCIAL YEAR OF 2023
PT INDOFARMA Tbk
Hereby the Board of Directors of PT Indofarma Tbk (“Company”) announce that the Annual
General Meeting of Shareholders for the Financial Year of 2023 of Company (“AGMS”) will
be held on Wednesday, June 26, 2024.
In accordance with Financial Services Authority Regulation Number 15/POJK.04/2020
concerning Plans and Implementation of General Meeting of Shareholders of Public
Companies in conjunction with Financial Services — Authority Regulation
Number 16/POJK.04/2020 concerning the Implementation of Electronic General Meeting
of Shareholders of Public Companies ("OJK Regulation”), the summons for the AGMS will be
made through the eASY.KSEI platform which can be accessed through
htpps://akses.ksei.co.id, the website of the e-GMS provider, the website
of the Indonesia Stock Exchange, and the website of the Company (www.indofarma.id) on
June 04, 2024.
Shareholders who are entitled to attend or be represented in the AGMS are Shareholders
whose names are registered in the Shareholders Register of the Company and/or owners
of the Company's share balances in the securities sub-account in the Collective Custody
Of PT Kustodian Sentral Efek Indonesia (“KSEI”) at the close of stock trading on the Indonesia
Stock Exchange on June 03, 2024.
In accordance with OJK Regulation and Article 23 of the Company's Articles of Association,
1 (one) Shareholder or more representing 1/20 (one twentieth) or more of the total shares
issued by the Company with valid voting rights and Series A Shareholders Dwi Warna has
the right to propose the agenda of the AGMS which must be submitted in writing to the
Board of Directors of the Company no later than 7 (seven) days before the date of the
summons for the AGMS, May 28, 2024, accompanied by the reasons and materials for the
proposed AGMS agenda, and does not conflict with the statutory regulations.
Jakarta, May 20, 2024
PT Indofarma Tbk
Board of Directors
A
Page 2 OCR 0.955
(/ indofarma mber of Biafarma Group PENGUMUMAN RAPAT UMUM PEMEGANG SAHAM TAHUNAN TAHUN BUKU 2023 PT INDOFARMA Tbk Bersama ini Direksi PT Indofarma Tbk (“Perseroan”) mengumumkan bahwa Rapat Umum Pemegang Saham Tahunan Tahun Buku 2023 Perseroan (“RUPST”) akan dilaksanakan pada hari Rabu, tanggal 26 Juni 2024. Sesuai dengan Peraturan Otoritas Jasa Keuangan Nomor 15/POJK.04/2020 tentang Rencana dan Penyelenggaraan Rapat Umum Pemegang Saham Perusahaan Terbuka juncto Peraturan Otoritas Jasa Keuangan Nomor 16/POJK.04/2020 tentang Pelaksanaan Rapat Umum Pemegang Saham Perusahaan Terbuka secara Elektronik (“Peraturan OJK”), maka pemanggilan RUPST akan dilakukan melalui plafform eASY.KSEI yang dapat diakses melalui htpps://akses.ksei.co.id, situs web penyedia e-RUPS, situs web Bursa Efek Indonesia, dan situs web Perseroan (www.indofarma.id) pada tanggal 04 Juni 2024. Para Pemegang Saham yang berhak menghadiri atau diwakili dalam RUPST adalah Para Pemegang Saham yang namanya tercatat dalam Daftar Pemegang Saham Perseroan dan/atau pemilik saldo saham Perseroan pada sub rekening efek di Penitipan Kolektif PT Kustodian Sentral Efek Indonesia (“KSEI”) pada penutupan perdagangan saham di Bursa Efek Indonesia pada tanggal 03 Juni 2024. Sesuai dengan Peraturan OJK dan Pasal 23 Anggaran Dasar Perseroan, 1 (satu) Pemegang Saham atau lebih yang mewakili 1/20 (satu per dua puluh) atau lebih dari jumlah seluruh saham yang telah dikeluarkan Perseroan dengan hak suara yang sah dan Pemegang Saham Seri A Dwi Warna berhak untuk mengusulkan mata acara RUPST yang wajib disampaikan secara tertulis kepada Direksi Perseroan paling lambat 7 (tujuh) hari sebelum tanggal Pemanggilan RUPST, yaitu tanggal 28 Mei 2024, dengan disertai alasan dan bahan usulan mata acara RUPST, serta tidak bertentangan dengan peraturan perundang-undangan. Jakarta, 20 Mei 2024 PT Indofarma Tbk Direksi A
Names mentioned 6 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Financial Services Authority
p.1
unresolved
org
Indonesia Stock Exchange
p.1 ×2
unresolved
org
PT Kustodian Sentral Efek Indonesia
p.1 ×3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.